Tech selloffs are rarely comfortable. But they can create opportunities. In 2026, several high-quality ASX growth names have been dragged lower amid broader weakness in technology stocks.
When sentiment turns against a sector, share prices can fall faster than fundamentals change. For investors willing to look past short-term volatility, I think three Aussie stocks stand out right now.
All three have fallen heavily this year. But I believe their long-term stories remain intact.
Image source: Getty Images
Life360 Inc. (ASX: 360)
Life360 operates a global family safety platform built around subscription revenue.
Its core app allows families to share location data and access safety features, with revenue increasingly driven by paid plans rather than advertising. That recurring revenue model is important. It creates visibility and scalability.
Growth stocks like Life360 often experience outsized share price swings when markets become risk-averse. But if subscriber growth, engagement, and monetisation continue to improve, the long-term value of the platform could be significantly higher than today's share price suggests.
If sentiment shifts back toward growth names, I think Life360 shares could rebound quickly.
Pro Medicus Ltd (ASX: PME)
Pro Medicus has long been one of the ASX's standout software success stories.
The company provides advanced medical imaging software to hospitals and healthcare providers globally. Its Visage platform is known for speed and performance, particularly when handling large imaging files.
The business model is capital-light, highly profitable, and backed by long-term contracts. Yet like many premium software companies, its share price has been caught up in the broader tech selloff caused by AI disruption concerns.
I do not believe AI will disrupt Pro Medicus. It has spent years building its world-class software, which is backed by patents and industry trust.
If its earnings growth continues, this current share price weakness could prove temporary.
Temple & Webster Group Ltd (ASX: TPW)
Temple & Webster is often viewed as a discretionary retail stock, but its online-only model gives it structural advantages.
The company operates without the burden of a large physical store network, allowing it to scale efficiently. Over time, it has invested in brand, logistics, and customer experience to strengthen its competitive position.
Retail and technology selloffs can overlap, and Temple & Webster has felt that pressure. But if consumer conditions stabilise and online penetration continues to grow, its earnings could recover faster than many expect.
For patient investors, I think this could be a chance to buy into Australia's leading online furniture retailer at a more reasonable price.
Why I think they could pop
I am not predicting a sudden spike next week.
But markets tend to overshoot in both directions. When high-growth stocks are sold indiscriminately, it creates a gap between share price and long-term potential.
If broader tech sentiment improves, or if these companies continue delivering strong operational results, investor confidence could return quickly.
Foolish takeaway
Life360, Pro Medicus, and Temple & Webster have all fallen heavily in 2026 amid a tech selloff.
That does not automatically make them bargains. But if their long-term growth stories remain intact, I think the recent weakness could present a compelling opportunity.
